EC 2.7.1.37 - obsolete, now divided into EC 2.7.11.1, EC 2.7.11.8, EC 2.7.11.9, EC 2.7.11.10, EC 2.7.11.11, EC 2.7.11.12, EC 2.7.11.13, EC 2.7.11.21, EC 2.7.11.22, EC 2.7.11.24, EC 2.7.11.25, EC 2.7.11.30 and EC 2.7.12.1

3D structures of EC 2.7.1.37 in Protein Data Bank

updated: 6 January 2022, 2:15

1. 1apm: 2.0 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with a Peptide Inhibitor and Detergent
2. 1aq1: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Staurosporine
3. 1atp: 2.2 Angstrom Refined Crystal Structure of The Catalytic Subunit of Camp-dependent Protein Kinase Complexed with Mnatp and a Peptide Inhibitor
4. 1b38: Human Cyclin-dependent Kinase 2
5. 1b39: Human Cyclin-dependent Kinase 2 Phosphorylated on Thr 160
6. 1b6c: Crystal Structure of The Cytoplasmic Domain of The Type I Tgf-beta Receptor in Complex with Fkbp12
7. 1bdy: C2 Domain from Protein Kinase C Delta
8. 1bkx: A Binary Complex of The Catalytic Subunit of Camp-dependent Protein Kinase and Adenosine Further Defines Conformational Flexibility
9. 1bx6: Crystal Structure of The Potent Natural Product Inhibitor Balanol in Complex with The Catalytic Subunit of Camp- Dependent Protein Kinase
10. 1ckp: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Purvalanol B
11. 1ctp: Structure of The Mammalian Catalytic Subunit of Camp- Dependent Protein Kinase and an Inhibitor Peptide Displays an Open Conformation
12. 1daw: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-amppnp
13. 1day: Crystal Structure of a Binary Complex of Protein Kinase Ck2 (alpha-subunit) and Mg-gmppnp
14. 1ddm: Solution Structure of The Numb Ptb Domain Complexed to a Nak Peptide
15. 1ds5: Dimeric Crystal Structure of The Alpha Subunit in Complex with Two Beta Peptides Mimicking The Architecture of The Tetrameric Protein Kinase Ck2 Holoenzyme.
16. 1e1v: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu2058
17. 1e1x: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor Nu6027
18. 1e9h: Thr 160 Phosphorylated Cdk2 - Human Cyclin A3 Complex with The Inhibitor Indirubin-5-sulphonate Bound
19. 1f0q: Crystal Structure of The Alpha Subunit of Protein Kinase Ck2 in Complex with The Nucleotide Competitive Inhibitor Emodin
20. 1fmo: Crystal Structure of a Polyhistidine-tagged Recombinant Catalytic Subunit of Camp-dependent Protein Kinase Complexed with The Peptide Inhibitor Pki(5-24) and Adenosine
21. 1fot: Structure of The Unliganded Camp-dependent Protein Kinase Catalytic Subunit from Saccharomyces Cerevisiae
22. 1fvt: The Structure of Cyclin-dependent Kinase 2 (cdk2) in Complex with an Oxindole Inhibitor
23. 1fvv: The Structure of Cdk2/cyclin a in Complex with an Oxindole Inhibitor
24. 1g3n: Structure of a P18(INK4C)-CDK6-K-CYCLIN Ternary Complex
25. 1gih: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
26. 1gii: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
27. 1gij: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
28. 1gng: Glycogen Synthase Kinase-3 Beta (gsk3) Complex with Frattide Peptide
29. 1gz8: Human Cyclin Dependent Kinase 2 Complexed with The Inhibitor 2-amino-6-(3'-methyl-2'-oxo)butoxypurine
30. 1h00: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
31. 1h07: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
32. 1h08: Cdk2 in Complex with a Disubstituted 2, 4-bis Anilino Pyrimidine Cdk4 Inhibitor
33. 1h0v: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[(r)-pyrrolidino-5'-yl]methoxypurine
34. 1h0w: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 2-amino-6-[cyclohex-3-enyl]methoxypurine
35. 1h8f: Glycogen Synthase Kinase 3 Beta.
36. 1hck: Human Cyclin-dependent Kinase 2
37. 1hcl: Human Cyclin-dependent Kinase 2
38. 1i09: Structure of Glycogen Synthase Kinase-3 (GSK3B)
39. 1ia9: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (amppnp Complex)
40. 1iah: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (adp-mg Complex)
41. 1iaj: Crystal Structure of The Atypical Protein Kinase Domain of a Trp Ca-channel, Chak (apo)
42. 1ias: Cytoplasmic Domain of Unphosphorylated Type I Tgf-beta Receptor Crystallized without Fkbp12
43. 1id0: Crystal Structure of The Nucleotide Bond Conformation of Phoq Kinase Domain
44. 1ik7: Crystal Structure of The Uncomplexed Pelle Death Domain
45. 1j1b: Binary Complex Structure of Human Tau Protein Kinase I with Amppnp
46. 1j1c: Binary Complex Structure of Human Tau Protein Kinase I with Adp
47. 1j3h: Crystal Structure of Apoenzyme Camp-dependent Protein Kinase Catalytic Subunit
48. 1j91: Crystal Structure of Z. Mays Ck2 Kinase Alpha Subunit in Complex with The Atp-competitive Inhibitor 4,5,6,7- Tetrabromobenzotriazole
49. 1jam: Crystal Structure of Apo-form of Z. Mays Ck2 Protein Kinase Alpha Subunit
50. 1jbp: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Substrate Peptide, Adp and Detergent
51. 1jlu: Crystal Structure of The Catalytic Subunit of Camp- Dependent Protein Kinase Complexed with a Phosphorylated Substrate Peptide and Detergent
52. 1jvp: Crystal Structure of Human Cdk2 (unphosphorylated) in Complex with Pkf049-365
53. 1jwh: Crystal Structure of Human Protein Kinase Ck2 Holoenzyme
54. 1ke5: Cdk2 Complexed with N-methyl-4-{[(2-oxo-1,2-dihydro-3h- Indol-3-ylidene)methyl]amino}benzenesulfonamide
55. 1ke6: Cyclin-dependent Kinase 2 (cdk2) Complexed with N-methyl-{4- [2-(7-oxo-6,7-dihydro-8h-[1,3]thiazolo[5,4-e]indol-8- Ylidene)hydrazino]phenyl}methanesulfonamide
56. 1ke7: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[(2,2- Dioxido-1,3-dihydro-2-benzothien-5-yl)amino]methylene}-5- (1,3-oxazol-5-yl)-1,3-dihydro-2h-indol-2-one
57. 1ke8: Cyclin-dependent Kinase 2 (cdk2) Complexed with 4-{[(2-oxo- 1,2-dihydro-3h-indol-3-ylidene)methyl]amino}-n-(1,3- Thiazol-2-yl)benzenesulfonamide
58. 1ke9: Cyclin-dependent Kinase 2 (cdk2) Complexed with 3-{[4- ({[amino(imino)methyl]aminosulfonyl)anilino]methylene}-2- Oxo-2,3-dihydro-1h-indole
59. 1ktz: Crystal Structure of The Human Tgf-beta Type II Receptor Extracellular Domain in Complex with Tgf-beta3
60. 1l3r: Crystal Structure of a Transition State Mimic of The Catalytic Subunit of Camp-dependent Protein Kinase
61. 1l6e: Solution Structure of The Docking and Dimerization Domain of Protein Kinase a Ii-alpha (riialpha D/d). Alternatively Called The N-terminal Dimerization Domain of The Regulatory Subunit of Protein Kinase A.
62. 1ll8: Structure and Interactions of Pas Kinase N-terminal Pas Domain: Model for Intramolecular Kinase Regulation
63. 1lp4: Crystal Structure of a Binary Complex of The Catalytic Subunit of Protein Kinase Ck2 with Mg-amppnp
64. 1lpu: Low Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
65. 1lr4: Room Temperature Crystal Structure of The Apo-form of The Catalytic Subunit of Protein Kinase Ck2 from Zea Mays
66. 1m2p: Crystal Structure of 1,8-di-hydroxy-4-nitro- Anthraquinone/ck2 Kinase Complex
67. 1m2q: Crystal Structure of 1,8-di-hydroxy-4-nitro-xanten-9- One/ck2 Kinase Complex
68. 1m2r: Crystal Structure of 5,8-di-amino-1,4-di-hydroxy- Anthraquinone/ck2 Kinase Complex
69. 1mby: Murine Sak Polo Domain
70. 1na7: Crystal Structure of The Catalytic Subunit of Human Protein Kinase Ck2
71. 1o6k: Structure of Activated Form of Pkb Kinase Domain S474D with Gsk3 Peptide and Amp-pnp
72. 1o6l: Crystal Structure of an Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex with Amp-pnp and Gsk3 Peptide
73. 1o9u: Glycogen Synthase Kinase 3 Beta Complexed with Axin Peptide
74. 1ogu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 2-arylamino-4-cyclohexylmethyl-5-nitroso-6-aminopyrimidine Inhibitor
75. 1oi9: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
76. 1oiq: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
77. 1oir: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
78. 1oit: Imidazopyridines: a Potent and Selective Class of Cyclin-dependent Kinase Inhibitors Identified through Structure-based Hybridisation
79. 1oiu: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
80. 1oiy: Structure of Human Thr160-phospho Cdk2/cyclin a Complexed with a 6-cyclohexylmethyloxy-2-anilino-purine Inhibitor
81. 1okv: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-ile-phe-nh2
82. 1okw: Cyclin a Binding Groove Inhibitor Ac-arg-arg-leu-asn- (m-cl-phe)-nh2
83. 1oky: Structure of Human Pdk1 Kinase Domain in Complex with Staurosporine
84. 1okz: Structure of Human Pdk1 Kinase Domain in Complex with Ucn-01
85. 1ol1: Cyclin a Binding Groove Inhibitor H-cit-cit-leu-ile- (p-f-phe)-nh2
86. 1ol2: Cyclin a Binding Groove Inhibitor H-arg-arg-leu-asn- (p-f-phe)-nh2
87. 1ol5: Structure of Aurora-a 122-403, Phosphorylated on Thr287, Thr288 and Bound to Tpx2 1-43
88. 1ol6: Structure of Unphosphorylated D274N Mutant of Aurora-a
89. 1ol7: Structure of Human Aurora-a 122-403 Phosphorylated on Thr287, Thr288
90. 1om1: Crystal Structure of Maize Ck2 Alpha in Complex with Iqa
91. 1ouk: The Structure of P38 Alpha in Complex with a Pyridinylimidazole Inhibitor
92. 1ouy: The Structure of P38 Alpha in Complex with a Dihydropyrido- Pyrimidine Inhibitor
93. 1ove: The Structure of P38 Alpha in Complex with a Dihydroquinolinone
94. 1oz1: P38 Mitogen-activated Kinase in Complex with 4-azaindole Inhibitor
95. 1pf8: Crystal Structure of Human Cyclin-dependent Kinase 2 Complexed with a Nucleoside Inhibitor
96. 1pjk: Crystal Structure of a C-terminal Deletion Mutant of Human Protein Kinase Ck2 Catalytic Subunit
97. 1plo: Transforming Growth Factor-beta Type II Receptor Extracellular Domain
98. 1py5: Crystal Structure of Tgf-beta Receptor I Kinase with Inhibitor
99. 1pyx: Gsk-3 Beta Complexed with Amp-pnp
100. 1q24: Pka Double Mutant Model of Pkb in Complex with Mgatp
101. 1q3d: Gsk-3 Beta Complexed with Staurosporine
102. 1q3w: Gsk-3 Beta Complexed with Alsterpaullone
103. 1q41: Gsk-3 Beta Complexed with Indirubin-3'-monoxime
104. 1q4l: Gsk-3 Beta Complexed with Inhibitor I-5
105. 1q5k: Crystal Structure of Glycogen Synthase Kinase 3 in Complexed with Inhibitor
106. 1q61: Pka Triple Mutant Model of Pkb
107. 1q62: Pka Double Mutant Model of Pkb
108. 1q8t: The Catalytic Subunit of Camp-dependent Protein Kinase (pka) in Complex with Rho-kinase Inhibitor Y-27632
109. 1q8u: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor H-1152p
110. 1q8w: The Catalytic Subunit of Camp-dependent Protein Kinase in Complex with Rho-kinase Inhibitor Fasudil (ha-1077)
111. 1qf8: Truncated Form of Casein Kinase II Beta Subunit (2-182) from Homo Sapiens
112. 1r0e: Glycogen Synthase Kinase-3 Beta in Complex with 3-indolyl-4- Arylmaleimide Inhibitor
113. 1r2a: The Molecular Basis for Protein Kinase a Anchoring Revealed by Solution Nmr
114. 1r39: The Structure of P38ALPHA
115. 1r3c: The Structure of P38ALPHA C162S Mutant
116. 1rdq: Hydrolysis of Atp in The Crystal of Y204A Mutant of Camp- Dependent Protein Kinase
117. 1re8: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 2
118. 1rej: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 1
119. 1rek: Crystal Structure of Camp-dependent Protein Kinase Complexed with Balanol Analog 8
120. 1rew: Structural Refinement of The Complex of Bone Morphogenetic Protein 2 and Its Type Ia Receptor
121. 1rgs: Regulatory Subunit of Camp Dependent Protein Kinase
122. 1rqf: Structure of Ck2 Beta Subunit Crystallized in The Presence of a P21WAF1 Peptide
123. 1rw8: Crystal Structure of Tgf-beta Receptor I Kinase with Atp Site Inhibitor
124. 1rwi: Extracellular Domain of Mycobacterium Tuberculosis Pknd
125. 1rwl: Extracellular Domain of Mycobacterium Tuberculosis Pknd
126. 1s4y: Crystal Structure of The Activin/actriib Extracellular Domain
127. 1s9i: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 2 (mek2)in a Complex with Ligand and Mgatp
128. 1s9j: X-ray Structure of The Human Mitogen-activated Protein Kinase Kinase 1 (mek1) in a Complex with Ligand and Mgatp
129. 1smh: Protein Kinase a Variant Complex with Completely Ordered N- Terminal Helix
130. 1stc: Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with Staurosporine
131. 1sve: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 1
132. 1svg: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 4
133. 1svh: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 8
134. 1syk: Crystal Structure of E230Q Mutant of Camp-dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation
135. 1szm: Dual Binding Mode of Bisindolylmaleimide 2 to Protein Kinase a (pka)
136. 1th8: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form II
137. 1thn: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Inhibitory Complex with Adp, Crystal Form I
138. 1tid: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa: Poised for Phosphorylation Complex with Atp, Crystal Form I
139. 1til: Crystal Structures of The Adp and Atp Bound Forms of The Bacillus Anti-sigma Factor Spoiiab in Complex with The Anti-anti-sigma Spoiiaa:poised for Phosphorylation Complex with Atp, Crystal Form II
140. 3e3p: Glycogen Synthase Kinase from Leishmania Major
141. 1tvo: The Structure of Erk2 in Complex with a Small Molecule Inhibitor
142. 1ua2: Crystal Structure of Human Cdk7
143. 1ukh: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
144. 1uki: Structural Basis for The Selective Inhibition of Jnk1 by The Scaffolding Protein Jip1 and Sp600125
145. 1urc: Cyclin a Binding Groove Inhibitor Ace-arg-lys-leu- Phe-gly
146. 1urw: Cdk2 in Complex with an Imidazo[1,2-b]pyridazine
147. 1uti: Mona/gads SH3C in Complex with Hpk Derived Peptide
148. 1uu3: Structure of Human Pdk1 Kinase Domain in Complex with Ly333531
149. 1uu7: Structure of Human Pdk1 Kinase Domain in Complex with Bim-2
150. 1uu8: Structure of Human Pdk1 Kinase Domain in Complex with Bim-1
151. 1uu9: Structure of Human Pdk1 Kinase Domain in Complex with Bim-3
152. 1uv5: Glycogen Synthase Kinase 3 Beta Complexed with 6-bromoindirubin-3'-oxime
153. 1uvr: Structure of Human Pdk1 Kinase Domain in Complex with Bim-8
154. 1uwh: The Complex of Wild Type B-raf and Bay439006
155. 1uwj: The Complex of Mutant V599E B-raf and Bay439006
156. 1v1k: Cdk2 in Complex with a Disubstituted 4, 6-bis Anilino Pyrimidine Cdk4 Inhibitor
157. 1vd2: Solution Structure of The Pb1 Domain of Pkciota
158. 1veb: Crystal Structure of Protein Kinase a in Complex with Azepane Derivative 5
159. 1vjy: Crystal Structure of a Naphthyridine Inhibitor of Human Tgf- Beta Type I Receptor
160. 1vyw: Structure of Cdk2/cyclin a with Pnu-292137
161. 1vyz: Structure of Cdk2 Complexed with Pnu-181227
162. 1vzo: The Structure of The N-terminal Kinase Domain of Msk1 Reveals a Novel Autoinhibitory Conformation for a Dual Kinase Protein
163. 1w0x: Crystals Structure of Human Cdk2 in Complex with The Inhibitor Olomoucine.
164. 1w1d: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Inositol (1,3,4,5)-tetrakisphosphate
165. 1w1g: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain Bound to Dic4-phosphatidylinositol (3,4,5)- Trisphosphate
166. 1w1h: Crystal Structure of The Pdk1 Pleckstrin Homology (ph) Domain
167. 1w7h: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
168. 1w82: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
169. 1w83: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
170. 1w84: P38 Kinase Crystal Structure in Complex with Small Molecule Inhibitor
171. 1w8c: Co-crystal Structure of 6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine and Monomeric Cdk2
172. 1w98: The Structural Basis of Cdk2 Activation by Cyclin E
173. 1wak: X-ray Structure of Srpk1
174. 1wbn: Fragment Based P38 Inhibitors
175. 1wbo: Fragment Based P38 Inhibitors
176. 1wbp: Srpk1 Bound to 9mer Docking Motif Peptide
177. 1wbs: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
178. 1wbt: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
179. 1wbv: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
180. 1wbw: Identification of Novel P38 Alpha Map Kinase Inhibitors Using Fragment-based Lead Generation.
181. 1wcc: Screening for Fragment Binding by X-ray Crystallography
182. 1wh4: Solution Structure of The Death Domain of Interleukin-1 Receptor-associated Kinase4 (irak4) from Mus Musculus
183. 1wmh: Crystal Structure of a Pb1 Domain Complex of Protein Kinase C Iota and Par6 Alpha
184. 1wmk: Human Death-associated Kinase Drp-1, Mutant S308D D40
185. 1wrz: Calmodulin Complexed with a Peptide from a Human Death- Associated Protein Kinase
186. 1wvw: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
187. 1wvx: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
188. 1wvy: Crystal Structures of Kinase Domain of Dap Kinase in Complex with Small Molecular Inhibitors
189. 1wxm: Solution Structure of The N-terminal Ras-binding Domain (rbd) in Human A-raf Kinase
190. 1wzy: Crystal Structure of Human Erk2 Complexed with a Pyrazolopyridazine Derivative
191. 1x9x: Solution Structure of Dimeric Sam Domain from Mapkkk Ste11
192. 1xh4: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
193. 1xh5: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
194. 1xh6: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
195. 1xh7: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
196. 1xh8: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
197. 1xh9: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
198. 1xha: Crystal Structures of Protein Kinase B Selective Inhibitors in Complex with Protein Kinase a and Mutants
199. 2xmy: Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional Cdk Inhibitors as Anticancer Agents
200. 1xo2: Crystal Structure of a Human Cyclin-dependent Kinase 6 Complex with a Flavonol Inhibitor, Fisetin
201. 1xqz: Crystal Structure of Hpim-1 Kinase at 2.1 a Resolution
202. 1xr1: Crystal Structure of Hpim-1 Kinase in Complex with Amp-pnp at 2.1 a Resolution
203. 1xte: Crystal Structure of Cisk-px Domain
204. 1xtn: Crystal Structure of Cisk-px Domain with Sulfates
205. 1xws: Crystal Structure of The Human Pim1 Kinase Domain
206. 2x1n: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
207. 1y8g: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Inactive Double Mutant with Selenomethionine
208. 2wxv: Structure of Cdk2-cyclin a with a Pyrazolo(4,3-h) Quinazoline-3-carboxamide Inhibitor
209. 1y8y: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
210. 1y91: Crystal Structure of Human Cdk2 Complexed with a Pyrazolo[1, 5-a]pyrimidine Inhibitor
211. 1ydr: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H7 Protein Kinase Inhibitor 1-(5- Isoquinolinesulfonyl)-2-methylpiperazine
212. 1yds: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H8 Protein Kinase Inhibitor [n-(2- Methylamino)ethyl]-5-isoquinolinesulfonamide
213. 1ydt: Structure of Camp-dependent Protein Kinase, Alpha-catalytic Subunit in Complex with H89 Protein Kinase Inhibitor N-[2- (4-bromocinnamylamino)ethyl]-5-isoquinoline
214. 1ygo: Solution Structure of The Pelle Death Domain
215. 1yhs: Crystal Structure of Pim-1 Bound to Staurosporine
216. 1yhv: Crystal Structure of Pak1 Kinase Domain with Two Point Mutations (K299R, T423E)
217. 1yhw: Crystal Structure of Pak1 Kinase Domain with One Point Mutations (K299R)
218. 1yi3: Crystal Structure of Pim-1 Bound to Ly294002
219. 1yi4: Structure of Pim-1 Bound to Adenosine
220. 2wpa: Optimisation of 6,6-dimethyl Pyrrolo 3,4-c Pyrazoles: Identification of Pha-793887, a Potent Cdk Inhibitor Suitable for Intravenous Dosing
221. 1ykr: Crystal Structure of Cdk2 with an Aminoimidazo Pyridine Inhibitor
222. 1yqj: Crystal Structure of P38 Alpha in Complex with a Selective Pyridazine Inhibitor
223. 1yr5: 1.7-a Structure of Calmodulin Bound to a Peptide from Dap Kinase
224. 1yrp: Catalytic Domain of Human Zip Kinase Phosphorylated at Thr265
225. 2wip: Structure of Cdk2-cyclin a Complexed with 8-anilino-1- Methyl-4,5-dihydro-1h-pyrazolo[4,3-h] Quinazoline-3- Carboxylic Acid
226. 2wih: Structure of Cdk2-cyclin a with Pha-848125
227. 2whb: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
228. 1yw2: Mutated Mus Musculus P38 Kinase (mp38)
229. 1ywr: Crystal Structure Analysis of Inactive P38 Kinase Domain in Complex with a Monocyclic Pyrazolone Inhibitor
230. 1ywv: Crystal Structures of Proto-oncogene Kinase Pim1: a Target of Aberrant Somatic Hypermutations in Diffuse Large Cell Lymphoma
231. 2wfy: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
232. 2wev: Truncation and Optimisation of Peptide Inhibitors of Cdk2, Cyclin a through Structure Guided Design
233. 1yxs: Crystal Structure of Kinase Pim1 with P123M Mutation
234. 1yxt: Crystal Structure of Kinase Pim1 in Complex with Amppnp
235. 1yxu: Crystal Structure of Kinase Pim1 in Complex with Amp
236. 1yxv: Crystal Structure of Kinase Pim1 in Complex with 3,4- Dihydroxy-1-methylquinolin-2(1h)-one
237. 1yxx: Crystal Structure of Kinase Pim1 in Complex with (3e)-3-[(4- Hydroxyphenyl)imino]-1h-indol-2(3h)-one
238. 1z5m: Crystal Structure of N1-[3-[[5-bromo-2-[[3-[(1- Pyrrolidinylcarbonyl)amino]phenyl]amino]-4- Pyrimidinyl]amino]propyl]-2,2-dimethylpropanediamide Complexed with Human Pdk1
239. 1z9x: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 3 Monomers in The Asymmetric Unit
240. 2w1h: Fragment-based Discovery of The Pyrazol-4-yl Urea (at9283), a Multi-targeted Kinase Inhibitor with Potent Aurora Kinase Activity
241. 1zlt: Crystal Structure of Chk1 Complexed with a Hymenaldisine Analog
242. 1zmu: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: Wild Type
243. 1zmv: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: K82R Mutant
244. 1zmw: Catalytic and Ubiqutin-associated Domains of Mark2/par-1: T208A/S212A Inactive Double Mutant
245. 1zoe: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
246. 1zog: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives
247. 1zoh: Crystal Structure of Protein Kinase Ck2 in Complex with Tbb- Derivatives Inhibitors
248. 1zsg: Beta Pix-sh3 Complexed with an Atypical Peptide from Alpha- Pak
249. 1zxa: Solution Structure of The Coiled-coil Domain of Cgmp- Dependent Protein Kinase Ia
250. 1zxe: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: D835N Inactivating Mutant in Apo Form
251. 1zy4: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant in Apo Form.
252. 1zy5: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: R794G Hyperactivating Mutant Complexed with Amppnp.
253. 1zyc: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type in Apo Form.
254. 1zyd: Crystal Structure of EIF2ALPHA Protein Kinase Gcn2: Wild- Type Complexed with Atp.
255. 1zyj: Human P38 Map Kinase in Complex with Inhibitor 1a
256. 1zys: Co-crystal Structure of Checkpoint Kinase Chk1 with a Pyrrolo-pyridine Inhibitor
257. 1zz2: Two Classes of P38ALPHA Map Kinase Inhibitors Having a Common Diphenylether Core but Exhibiting Divergent Binding Modes
258. 1zzl: Crystal Structure of P38 with Triazolopyridine
259. 2a0c: Human Cdk2 in Complex with Olomoucine Ii, a Novel 2,6,9- Trisubstituted Purine Cyclin-dependent Kinase Inhibitor
260. 2a0t: Nmr Structure of The Fha1 Domain of Rad53 in Complex with a Biological Relevant Phosphopeptide Derived from Madt1
261. 2a27: Human Drp-1 Kinase, W305S S308A D40 Mutant, Crystal Form with 8 Monomers in The Asymmetric Unit
262. 2a2a: High-resolution Crystallographic Analysis of The Autoinhibited Conformation of a Human Death-associated Protein Kinase
263. 2a4l: Human Cyclin-dependent Kinase 2 in Complex with Roscovitine
264. 2a9i: Molecular Structure of The Interleukin-1 Receptor- Associated Kinase-4 Death Domain
265. 2ac3: Structure of Human Mnk2 Kinase Domain
266. 2ac5: Structure of Human Mnk2 Kinase Domain Mutant D228G
267. 2v22: Replace: a Strategy for Iterative Design of Cyclin Binding Groove Inhibitors
268. 2v0d: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
269. 2uzo: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
270. 2uzn: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
271. 2uzl: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
272. 2uze: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
273. 2uzd: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
274. 2uzb: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
275. 2ayp: Crystal Structure of Chk1 with an Indol Inhibitor
276. 2b1p: Inhibitor Complex of Jnk3
277. 2b52: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Dph- 042562
278. 2b53: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Din- 234325
279. 2b54: Human Cyclin Dependent Kinase 2 (ckd2)complexed with Din- 232305
280. 2b55: Human Cyclin Dependent Kinase 2 (cdk2) Complexed with Indenopyraxole Din-101312
281. 2b9f: Crystal Structure of Non-phosphorylated Fus3
282. 2b9h: Crystal Structure of Fus3 with a Docking Motif from Ste7
283. 2b9i: Crystal Structure of Fus3 with a Docking Motif from Msg5
284. 2b9j: Crystal Structure of Fus3 with a Docking Motif from Far1
285. 2baj: P38ALPHA Bound to Pyrazolourea
286. 2bak: P38ALPHA Map Kinase Bound to Mpaq
287. 2bal: P38ALPHA Map Kinase Bound to Pyrazoloamine
288. 2baq: P38ALPHA Bound to Ro3201195
289. 2bhe: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 5-bromo-indirubine
290. 2bhh: Human Cyclin Dependent Protein Kinase 2 in Complex with The Inhibitor 4-hydroxypiperindinesulfonyl-indirubine
291. 2bik: Human Pim1 Phosphorylated on Ser261
292. 2bil: The Human Protein Kinase Pim1 in Complex with Its Consensus Peptide Pimtide
293. 2biy: Structure of PDK1-S241A Mutant Kinase Domain
294. 2bkz: Structure of Cdk2-cyclin a with Pha-404611
295. 2bmc: Aurora-2 T287D T288D Complexed with Pha-680632
296. 2bpm: Structure of Cdk2-cyclin a with Pha-630529
297. 2br1: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
298. 2brb: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
299. 2brg: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
300. 2brh: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
301. 2brm: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
302. 2brn: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
303. 2bro: Structure-based Design of Novel Chk1 Inhibitors: Insights into Hydrogen Bonding and Protein-ligand Affinity
304. 2btr: Structure of Cdk2 Complexed with Pnu-198873
305. 2bts: Structure of Cdk2 Complexed with Pnu-230032
306. 2buj: Crystal Structure of The Human Serine-threonine Kinase 16 in Complex with Staurosporine
307. 2bva: Crystal Structure of The Human P21-activated Kinase 4
308. 2bzh: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru1
309. 2bzi: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru2
310. 2bzj: Crystal Structure of The Human Pim1 in Complex with a Ruthenium Organometallic Ligand Ru3
311. 2bzk: Crystal Structure of The Human Pim1 in Complex with Amppnp and Pimtide
312. 2c1a: Structure of Camp-dependent Protein Kinase Complexed with Isoquinoline-5-sulfonic Acid (2-(2-(4-chlorobenzyloxy) Ethylamino)ethyl)amide
313. 2c1b: Structure of Camp-dependent Protein Kinase Complexed with ( 4r,2s)-5'-(4-(4-chlorobenzyloxy)pyrrolidin-2- Ylmethanesulfonyl)isoquinoline
314. 2c30: Crystal Structure of The Human P21-activated Kinase 6
315. 2c3i: Crystal Structure of Human Pim1 in Complex with Imidazopyridazin I
316. 2c3j: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
317. 2c3k: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
318. 2c3l: Identification of a Buried Pocket for Potent and Selective Inhibition of Chk1: Prediction and Verification
319. 2c4g: Structure of Cdk2-cyclin a with Pha-533514
320. 2c5n: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
321. 2c5o: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
322. 2c5v: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
323. 2c5x: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
324. 2c5y: Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design
325. 2c60: Crystal Structure of Human Mitogen-activated Protein Kinase Kinase Kinase 3 Isoform 2 Phox Domain at 1.25 a Resolution
326. 2c68: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
327. 2c69: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
328. 2c6d: Aurora a Kinase Activated Mutant (T287D) in Complex with Adpnp
329. 2c6e: Aurora a Kinase Activated Mutant (T287D) in Complex with a 5-aminopyrimidinyl Quinazoline Inhibitor
330. 2c6i: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
331. 2c6k: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
332. 2c6l: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
333. 2c6m: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
334. 2c6o: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
335. 2c6t: Crystal Structure of The Human Cdk2 Complexed with The Triazolopyrimidine Inhibitor
336. 2cdz: Crystal Structure of The Human P21-activated Kinase 4 in Complex with CGP74514A
337. 2cgu: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
338. 2cgv: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
339. 2cgw: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
340. 2cgx: Identification of Chemically Diverse Chk1 Inhibitors by Receptor-based Virtual Screening
341. 2cjm: Mechanism of Cdk Inhibition by Active Site Phosphorylation: Cdk2 Y15P T160P in Complex with Cyclin a Structure
342. 2clx: 4-arylazo-3,5-diamino-1h-pyrazole Cdk Inhibitors: Sar Study, Crystal Structure in Complex with Cdk2, Selectivity, and Cellular Effects
343. 2cos: Solution Structure of Rsgi Ruh-038, a Uba Domain from Mouse Lats2 (large Tumor Suppressor Homolog 2)
344. 2cpk: Crystal Structure of The Catalytic Subunit of Cyclic Adenosine Monophosphate-dependent Protein Kinase
345. 2cu1: Solution Structure of The Pb1 Domain of Human Protein Kinase MEKK2B
346. 2df6: Crystal Structure of The Sh3 Domain of Betapix in Complex with a High Affinity Peptide from Pak2
347. 2drn: Docking and Dimerization Domain (d/d) of The Type Ii-alpha Regulatory Subunity of Protein Kinase a (pka) in Complex with a Peptide from an A-kinase Anchoring Protein
348. 2erz: Crystal Structure of C-amp Dependent Kinase (pka) Bound to Hydroxyfasudil
349. 2esm: Crystal Structure of Rock 1 Bound to Fasudil
350. 2etk: Crystal Structure of Rock 1 Bound to Hydroxyfasudil
351. 2etr: Crystal Structure of Rock I Bound to Y-27632
352. 2euf: X-ray Structure of Human Cdk6-vcyclin in Complex with The Inhibitor Pd0332991
353. 2eva: Structural Basis for The Interaction of Tak1 Kinase with Its Activating Protein Tab1
354. 2ewa: Dual Binding Mode of Pyridinylimidazole to Map Kinase P38
355. 2exc: Inhibitor Complex of Jnk3
356. 2exm: Human Cdk2 in Complex with Isopentenyladenine
357. 2ezw: Solution Structure of The Docking and Dimerization Domain of The Type I Alpha Regulatory Subunit of Protein Kinase a (rialpha D/d)
358. 2f2c: X-ray Structure of Human Cdk6-vcyclinwith The Inhibitor Aminopurvalanol
359. 2f2u: Crystal Structure of The Rho-kinase Kinase Domain
360. 2f49: Crystal Structure of Fus3 in Complex with a Ste5 Peptide
361. 2f57: Crystal Structure of The Human P21-activated Kinase 5
362. 2f7e: Pka Complexed with (s)-2-(1h-indol-3-yl)-1-(5-isoquinolin-6- Yl-pyridin-3-yloxymethyl-etylamine
363. 2f7x: Protein Kinase a Bound to (s)-2-(1h-indol-3-yl)-1-[5-((e)-2- Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
364. 2f7z: Protein Kinase a Bound to (r)-1-(1h-indol-3-ylmethyl)-2-(2- Pyridin-4-yl-[1,7]naphtyridin-5-yloxy)-ehylamine
365. 2f9g: Crystal Structure of Fus3 Phosphorylated on Tyr182
366. 2fa2: Crystal Structure of Fus3 without a Peptide from Ste5
367. 2fb8: Structure of The B-raf Kinase Domain Bound to Sb-590885
368. 2fk9: Human Protein Kinase C, Eta
369. 2fsl: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-a
370. 2fsm: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327S) Activating Mutant Form-b
371. 2fso: Mitogen Activated Protein Kinase P38ALPHA (D176A) Activating Mutant
372. 2fst: Mitogen Activated Protein Kinase P38ALPHA (D176A+F327L) Activating Mutant
373. 2fum: Catalytic Domain of Protein Kinase Pknb from Mycobacterium Tuberculosis in Complex with Mitoxantrone
374. 2fvd: Cyclin Dependent Kinase 2 (cdk2) with Diaminopyrimidine Inhibitor
375. 2fys: Crystal Structure of Erk2 Complex with Kim Peptide Derived from Mkp3
376. 2g01: Pyrazoloquinolones as Novel, Selective Jnk1 Inhibitors
377. 2g9x: Structure of Thr 160 Phosphorylated Cdk2/cyclin a in Complex with The Inhibitor Nu6271
378. 2gbl: Crystal Structure of Full Length Circadian Clock Protein Kaic with Phosphorylation Sites
379. 2gcd: Tao2 Kinase Domain-staurosporine Structure
380. 2gdo: 4-(aminoalkylamino)-3-benzimidazole-quinolinones as Potent Chk1 Inhibitors
381. 2gfc: Camp-dependent Protein Kinase Pka Catalytic Subunit with Pki-5-24
382. 2gfs: P38 Kinase Crystal Structure in Complex with Ro3201195
383. 2ghg: H-chk1 Complexed with A431994
384. 2ghl: Mutant Mus Musculus P38 Kinase Domain in Complex with Inhibitor Pg-874743
385. 2ghm: Mutated Map Kinase P38 (mus Musculus) in Complex with Inhbitor Pg-895449
386. 2gu8: Discovery of 2-pyrimidyl-5-amidothiophenes as Novel and Potent Inhibitors for Akt: Synthesis and Sar Studies
387. 2h9r: Docking and Dimerization Domain (d/d) of The Regulatory Subunit of The Type Ii-alpha Camp-dependent Protein Kinase a Associated with a Peptide Derived from an A-kinase Anchoring Protein (akap)
388. 2iw6: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
389. 2iw8: Structure of Human Thr160-phospho Cdk2-cyclin a F82H-L83V- H84D Mutant with an O6-cyclohexylmethylguanine Inhibitor
390. 2iw9: Structure of Human Thr160-phospho Cdk2-cyclin a Complexed with a Bisanilinopyrimidine Inhibitor
391. 2j0i: Crystal Structure of The Human P21-activated Kinase 4
392. 2j4z: Structure of Aurora-2 in Complex with Pha-680626
393. 2j9m: Crystal Structure of Cdk2 in Complex with Macrocyclic Aminopyrimidine
394. 3ndm: Crystal Structure of Rho-associated Protein Kinase (rock1) with a Potent Isoquinolone Derivative
395. 2xix: Protein Kinase Pim-1 in Complex with Fragment-1 from Crystallographic Fragment Screen
396. 2xiy: Protein Kinase Pim-1 in Complex with Fragment-2 from Crystallographic Fragment Screen
397. 2xiz: Protein Kinase Pim-1 in Complex with Fragment-3 from Crystallographic Fragment Screen
398. 2xj0: Protein Kinase Pim-1 in Complex with Fragment-4 from Crystallographic Fragment Screen
399. 2xj1: Protein Kinase Pim-1 in Complex with Small Molecule Inibitor
400. 3pna: Crystal Structure of Camp Bound (91-244)ria Subunit of Camp-dependent Protein Kinase
401. 4a7c: Crystal Structure of Pim1 Kinase with Etp46546
402. 4a9y: P38ALPHA Map Kinase Bound to Cmpd 8
403. 4aa0: P38ALPHA Map Kinase Bound to Cmpd 2
404. 4aa4: P38ALPHA Map Kinase Bound to Cmpd 22
405. 4aa5: P38ALPHA Map Kinase Bound to Cmpd 33
406. 4app: Crystal Structure of The Human P21-activated Kinase 4 in Complex with (s)-n-(5-(3-benzyl-1-methylpiperazine-4- Carbonyl)-6,6-dimethyl-1,4,5,6-tetrahydropyrrolo(3,4-c) Pyrazol-3-yl)-3-phenoxybenzamide
407. 4alu: Benzofuropyrimidinone Inhibitors of Pim-1
408. 4alv: Benzofuropyrimidinone Inhibitors of Pim-1
409. 4alw: Benzofuropyrimidinone Inhibitors of Pim-1
410. 4g1w: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 7-fluoro-3- [4-(2-hydroxy-ethanesulfonyl)-benzyl]-4-oxo-1-phenyl-1,4-dihydro- Quinoline-2-carboxylic Acid Methyl Ester
411. 4hys: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-(4- Indazol-1-yl-pyrimidin-2-ylamino)-cyclohexan
412. 4hyu: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(3- Methanesulfonyl-propoxy)-indazol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan
413. 4izy: Crystal Structure of Jnk1 in Complex with Jip1 Peptide and 4-{4-[4-(4- Methanesulfonyl-piperidin-1-yl)-indol-1-yl]-pyrimidin-2-ylamino}- Cyclohexan